<?xml version="1.0" encoding="UTF-8"?>
<p>In homeostatic doses, the mistletoe preparations Iscador, Eurixor, Helixor, Abnoba‐viscum, and Isorel standardized for the content of mistletoe lectin 1 (1 ng/kg) are widely used in Europe as alternative adjuvant therapies against colon, oral, lung, pancreatic, and breast cancers.
 <xref rid="med21743-bib-0124" ref-type="ref">
  <sup>124</sup>
 </xref> The mistletoe extracts boost immunity, delay tumor progression, improve the quality of life, and increase survival and lifespan of cancer patients by helping with coping, fatigue, sleep, exhaustion, energy, nausea, vomiting, appetite, depression, anxiety, the ability to work, and emotional and functional well‐being.
 <xref rid="med21743-bib-0125" ref-type="ref">
  <sup>125</sup>
 </xref>, 
 <xref rid="med21743-bib-0126" ref-type="ref">
  <sup>126</sup>
 </xref>, 
 <xref rid="med21743-bib-0127" ref-type="ref">
  <sup>127</sup>
 </xref>, 
 <xref rid="med21743-bib-0128" ref-type="ref">
  <sup>128</sup>
 </xref> Mistletoe treatment also alleviates the adverse effects from chemotherapies.
 <xref rid="med21743-bib-0129" ref-type="ref">
  <sup>129</sup>
 </xref>
</p>
